| 0 |
COAGULATION FACTOR LEVEL ABNORMAL |
1 |
0.1667 |
| 1 |
HEPATIC HYPOPERFUSION |
1 |
0.1429 |
| 2 |
DENTAL BONE GRAFT |
1 |
0.0286 |
| 3 |
CATHETER SITE NECROSIS |
1 |
0.0263 |
| 4 |
BLOOD FIBRINOGEN DECREASED |
29 |
0.0254 |
| 5 |
PARAINFLUENZA VIRUS INFECTION |
2 |
0.0194 |
| 6 |
CATHETER SITE PHLEBITIS |
1 |
0.0192 |
| 7 |
PULMONARY BLASTOMYCOSIS |
2 |
0.0174 |
| 8 |
SUSPECTED DRUG-INDUCED LIVER INJURY |
3 |
0.0150 |
| 9 |
STENOTROPHOMONAS MALTOPHILIA PNEUMONIA |
1 |
0.0145 |
| 10 |
DISSEMINATED BLASTOMYCOSIS |
2 |
0.0117 |
| 11 |
VIRAL HEPATITIS CARRIER |
1 |
0.0114 |
| 12 |
HYPOFIBRINOGENAEMIA |
11 |
0.0111 |
| 13 |
GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY |
2 |
0.0086 |
| 14 |
PASTEURELLA INFECTION |
1 |
0.0078 |
| 15 |
PNEUMONIA ACINETOBACTER |
1 |
0.0073 |
| 16 |
SERRATIA BACTERAEMIA |
1 |
0.0068 |
| 17 |
PERIPANCREATIC FLUID COLLECTION |
1 |
0.0066 |
| 18 |
BLASTOMYCOSIS |
3 |
0.0062 |
| 19 |
PULMONARY MUCORMYCOSIS |
3 |
0.0057 |
| 20 |
ACINETOBACTER TEST POSITIVE |
1 |
0.0052 |
| 21 |
VOLVULUS OF SMALL BOWEL |
1 |
0.0051 |
| 22 |
MYCOBACTERIUM TEST POSITIVE |
1 |
0.0049 |
| 23 |
ACUTE ON CHRONIC LIVER FAILURE |
1 |
0.0046 |
| 24 |
MYCOBACTERIUM ABSCESSUS INFECTION |
3 |
0.0042 |
| 25 |
PERIPHERAL VEIN THROMBOSIS |
1 |
0.0042 |
| 26 |
CALCIUM IONISED DECREASED |
1 |
0.0041 |
| 27 |
INCISION SITE DISCHARGE |
1 |
0.0040 |
| 28 |
DISEASE SUSCEPTIBILITY |
1 |
0.0036 |
| 29 |
CATHETER SITE CELLULITIS |
1 |
0.0034 |
| 30 |
CARDIAC FUNCTION TEST ABNORMAL |
1 |
0.0034 |
| 31 |
COMPLICATIONS OF TRANSPLANTED LUNG |
1 |
0.0033 |
| 32 |
HEPATIC ISCHAEMIA |
1 |
0.0032 |
| 33 |
FAECAL OCCULT BLOOD POSITIVE |
1 |
0.0028 |
| 34 |
B-CELL TYPE ACUTE LEUKAEMIA |
2 |
0.0027 |
| 35 |
PANCREATIC ENLARGEMENT |
1 |
0.0027 |
| 36 |
HYDROURETER |
1 |
0.0026 |
| 37 |
TRANSPLANTATION COMPLICATION |
1 |
0.0024 |
| 38 |
PANCREATIC ENZYMES INCREASED |
3 |
0.0020 |
| 39 |
ACINETOBACTER INFECTION |
2 |
0.0018 |
| 40 |
MYOCARDIAL NECROSIS MARKER INCREASED |
3 |
0.0018 |
| 41 |
HAEMATOMA INFECTION |
1 |
0.0017 |
| 42 |
ANAL INFLAMMATION |
1 |
0.0016 |
| 43 |
CUTANEOUS SYMPTOM |
1 |
0.0015 |
| 44 |
ENTEROCOCCAL INFECTION |
7 |
0.0014 |
| 45 |
HYPERTRANSAMINASAEMIA |
10 |
0.0014 |
| 46 |
INFECTION PARASITIC |
1 |
0.0013 |
| 47 |
URETERIC STENOSIS |
1 |
0.0012 |
| 48 |
VASOSPASM |
1 |
0.0011 |
| 49 |
PNEUMONIA KLEBSIELLA |
2 |
0.0011 |
| 50 |
PROTHROMBIN LEVEL DECREASED |
1 |
0.0011 |
| 51 |
HYPOPROTEINAEMIA |
2 |
0.0011 |
| 52 |
BLOOD URINE |
1 |
0.0010 |
| 53 |
PROTHROMBIN TIME PROLONGED |
6 |
0.0010 |
| 54 |
PHLEBITIS |
5 |
0.0010 |
| 55 |
CAROTID ARTERIOSCLEROSIS |
1 |
0.0010 |
| 56 |
KLEBSIELLA SEPSIS |
1 |
0.0009 |
| 57 |
MUCOSAL HAEMORRHAGE |
1 |
0.0009 |
| 58 |
BILIRUBIN CONJUGATED INCREASED |
2 |
0.0009 |
| 59 |
PROCALCITONIN INCREASED |
1 |
0.0009 |
| 60 |
FEBRILE INFECTION |
1 |
0.0008 |
| 61 |
PNEUMOCYSTIS JIROVECII INFECTION |
1 |
0.0008 |
| 62 |
INFUSION SITE EXTRAVASATION |
5 |
0.0008 |
| 63 |
WHITE MATTER LESION |
1 |
0.0008 |
| 64 |
TROPONIN T INCREASED |
1 |
0.0008 |
| 65 |
SUBCUTANEOUS HAEMATOMA |
1 |
0.0008 |
| 66 |
SLOW RESPONSE TO STIMULI |
1 |
0.0008 |
| 67 |
ACQUIRED GENE MUTATION |
1 |
0.0008 |
| 68 |
PNEUMONIA FUNGAL |
3 |
0.0008 |
| 69 |
MYCOBACTERIUM AVIUM COMPLEX INFECTION |
2 |
0.0007 |
| 70 |
GASTRIC PERFORATION |
2 |
0.0007 |
| 71 |
ISCHAEMIC HEPATITIS |
1 |
0.0007 |
| 72 |
N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED |
1 |
0.0007 |
| 73 |
ATYPICAL MYCOBACTERIAL INFECTION |
1 |
0.0007 |
| 74 |
TRACHEOSTOMY |
1 |
0.0007 |
| 75 |
TOOTH DISCOLOURATION |
2 |
0.0007 |
| 76 |
PNEUMONIA PNEUMOCOCCAL |
1 |
0.0007 |
| 77 |
BRAIN HERNIATION |
2 |
0.0007 |
| 78 |
CRANIOCEREBRAL INJURY |
2 |
0.0007 |
| 79 |
COAGULOPATHY |
11 |
0.0007 |
| 80 |
PNEUMONIA PSEUDOMONAL |
1 |
0.0007 |
| 81 |
METABOLIC ALKALOSIS |
1 |
0.0006 |
| 82 |
INTERCEPTED PRODUCT DISPENSING ERROR |
1 |
0.0006 |
| 83 |
ELECTROLYTE IMBALANCE |
7 |
0.0006 |
| 84 |
ENTEROBACTER INFECTION |
1 |
0.0006 |
| 85 |
SALMONELLOSIS |
1 |
0.0006 |
| 86 |
GASTROINTESTINAL OEDEMA |
1 |
0.0006 |
| 87 |
PATHOGEN RESISTANCE |
5 |
0.0005 |
| 88 |
WOUND HAEMORRHAGE |
2 |
0.0005 |
| 89 |
SYSTEMIC INFLAMMATORY RESPONSE SYNDROME |
2 |
0.0005 |
| 90 |
GENE MUTATION |
1 |
0.0005 |
| 91 |
BLOOD ALBUMIN DECREASED |
4 |
0.0005 |
| 92 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
14 |
0.0005 |
| 93 |
CHOLANGITIS SCLEROSING |
1 |
0.0005 |
| 94 |
BODY TEMPERATURE FLUCTUATION |
1 |
0.0005 |
| 95 |
DISTRIBUTIVE SHOCK |
1 |
0.0004 |
| 96 |
PANCREATITIS NECROTISING |
1 |
0.0004 |
| 97 |
NEUROLOGICAL DECOMPENSATION |
1 |
0.0004 |
| 98 |
THROMBOTIC MICROANGIOPATHY |
4 |
0.0004 |
| 99 |
LIPASE INCREASED |
3 |
0.0004 |
| 100 |
ABDOMINAL INFECTION |
1 |
0.0004 |
| 101 |
PULMONARY ALVEOLAR HAEMORRHAGE |
2 |
0.0004 |
| 102 |
DRUG TOLERANCE DECREASED |
1 |
0.0004 |
| 103 |
OESOPHAGEAL STENOSIS |
1 |
0.0004 |
| 104 |
RESPIRATORY SYMPTOM |
1 |
0.0004 |
| 105 |
LACTIC ACIDOSIS |
11 |
0.0003 |
| 106 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
6 |
0.0003 |
| 107 |
BLOOD CULTURE POSITIVE |
1 |
0.0003 |
| 108 |
EMBOLISM VENOUS |
1 |
0.0003 |
| 109 |
CHEST X-RAY ABNORMAL |
1 |
0.0003 |
| 110 |
DUODENITIS |
1 |
0.0003 |
| 111 |
PORTAL HYPERTENSION |
1 |
0.0003 |
| 112 |
MULTIPLE-DRUG RESISTANCE |
1 |
0.0003 |
| 113 |
PORTAL VEIN THROMBOSIS |
1 |
0.0003 |
| 114 |
BLOOD BILIRUBIN INCREASED |
8 |
0.0003 |
| 115 |
HYPERBILIRUBINAEMIA |
3 |
0.0003 |
| 116 |
THROMBOTIC THROMBOCYTOPENIC PURPURA |
1 |
0.0003 |
| 117 |
LUNG TRANSPLANT |
1 |
0.0003 |
| 118 |
FIBRIN D DIMER INCREASED |
1 |
0.0003 |
| 119 |
SKIN WEEPING |
1 |
0.0003 |
| 120 |
APPARENT DEATH |
1 |
0.0003 |
| 121 |
RENAL TRANSPLANT |
1 |
0.0003 |
| 122 |
AMYLASE INCREASED |
1 |
0.0003 |
| 123 |
PROTEIN TOTAL DECREASED |
1 |
0.0003 |
| 124 |
HYPOCALCAEMIA |
5 |
0.0003 |
| 125 |
REHABILITATION THERAPY |
1 |
0.0003 |
| 126 |
BRONCHOPULMONARY ASPERGILLOSIS |
2 |
0.0003 |
| 127 |
APNOEA |
2 |
0.0003 |
| 128 |
PULMONARY HAEMORRHAGE |
2 |
0.0003 |
| 129 |
OESOPHAGEAL CANDIDIASIS |
1 |
0.0003 |
| 130 |
CEREBRAL ATROPHY |
1 |
0.0003 |
| 131 |
EXTRAVASATION |
1 |
0.0002 |
| 132 |
AORTIC DISSECTION |
1 |
0.0002 |
| 133 |
DRUG RESISTANCE |
6 |
0.0002 |
| 134 |
PULMONARY FUNCTION TEST DECREASED |
1 |
0.0002 |
| 135 |
CYTOMEGALOVIRUS VIRAEMIA |
1 |
0.0002 |
| 136 |
SUSPECTED OFF LABEL USE |
1 |
0.0002 |
| 137 |
BLOOD PRESSURE SYSTOLIC DECREASED |
1 |
0.0002 |
| 138 |
ACUTE GRAFT VERSUS HOST DISEASE |
1 |
0.0002 |
| 139 |
SHOCK |
5 |
0.0002 |
| 140 |
PANCREATITIS |
11 |
0.0002 |
| 141 |
PRESCRIBED OVERDOSE |
4 |
0.0002 |
| 142 |
LIVER INJURY |
5 |
0.0002 |
| 143 |
INFLAMMATORY MARKER INCREASED |
1 |
0.0002 |
| 144 |
HEPATIC ENZYME ABNORMAL |
1 |
0.0002 |
| 145 |
PNEUMOCYSTIS JIROVECII PNEUMONIA |
2 |
0.0002 |
| 146 |
KLEBSIELLA INFECTION |
1 |
0.0002 |
| 147 |
ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED |
1 |
0.0002 |
| 148 |
POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER |
1 |
0.0002 |
| 149 |
ENDOCARDITIS |
1 |
0.0002 |
| 150 |
DRUG-INDUCED LIVER INJURY |
6 |
0.0002 |
| 151 |
ANAL FISSURE |
1 |
0.0002 |
| 152 |
INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS |
1 |
0.0002 |
| 153 |
TRANSAMINASES INCREASED |
4 |
0.0002 |
| 154 |
MYOCARDIAL ISCHAEMIA |
2 |
0.0002 |
| 155 |
PERICARDIAL EFFUSION |
4 |
0.0002 |
| 156 |
BACTERAEMIA |
2 |
0.0002 |
| 157 |
PIGMENTATION DISORDER |
1 |
0.0002 |
| 158 |
THROMBOCYTOPENIA |
18 |
0.0002 |
| 159 |
SEPTIC SHOCK |
7 |
0.0002 |
| 160 |
MYDRIASIS |
2 |
0.0002 |
| 161 |
C-REACTIVE PROTEIN ABNORMAL |
1 |
0.0002 |
| 162 |
ASPERGILLUS INFECTION |
1 |
0.0002 |
| 163 |
LEFT VENTRICULAR DYSFUNCTION |
1 |
0.0001 |
| 164 |
PNEUMONITIS |
4 |
0.0001 |
| 165 |
PARAESTHESIA ORAL |
2 |
0.0001 |
| 166 |
ASCITES |
4 |
0.0001 |
| 167 |
HAEMORRHAGE INTRACRANIAL |
2 |
0.0001 |
| 168 |
HYDRONEPHROSIS |
1 |
0.0001 |
| 169 |
PANCREATITIS ACUTE |
3 |
0.0001 |
| 170 |
HEPATIC FAILURE |
4 |
0.0001 |
| 171 |
DEVICE PHYSICAL PROPERTY ISSUE |
1 |
0.0001 |
| 172 |
HYPOALBUMINAEMIA |
1 |
0.0001 |
| 173 |
PNEUMOTHORAX |
2 |
0.0001 |
| 174 |
SHOCK HAEMORRHAGIC |
1 |
0.0001 |
| 175 |
CEREBRAL INFARCTION |
3 |
0.0001 |
| 176 |
POLYURIA |
1 |
0.0001 |
| 177 |
PSEUDOMONAS INFECTION |
1 |
0.0001 |
| 178 |
MYOPATHY |
1 |
0.0001 |
| 179 |
SPINAL OSTEOARTHRITIS |
1 |
0.0001 |
| 180 |
RESPIRATORY RATE INCREASED |
1 |
0.0001 |
| 181 |
OFF LABEL USE |
98 |
0.0001 |
| 182 |
ELECTROCARDIOGRAM QT PROLONGED |
4 |
0.0001 |
| 183 |
PNEUMONIA BACTERIAL |
1 |
0.0001 |
| 184 |
HEPATIC STEATOSIS |
2 |
0.0001 |
| 185 |
HEPATIC ENCEPHALOPATHY |
1 |
0.0001 |
| 186 |
SPUTUM DISCOLOURED |
1 |
0.0001 |
| 187 |
GASTRIC ULCER |
2 |
0.0001 |
| 188 |
DRUG INTOLERANCE |
10 |
0.0001 |
| 189 |
SALIVARY HYPERSECRETION |
1 |
0.0001 |
| 190 |
PLEURAL EFFUSION |
6 |
0.0001 |
| 191 |
DRY THROAT |
1 |
0.0001 |
| 192 |
SUBARACHNOID HAEMORRHAGE |
1 |
0.0001 |
| 193 |
GASTROINTESTINAL HAEMORRHAGE |
8 |
0.0001 |
| 194 |
RENAL PAIN |
1 |
0.0001 |
| 195 |
LIVER FUNCTION TEST INCREASED |
2 |
0.0001 |
| 196 |
ALTERED STATE OF CONSCIOUSNESS |
2 |
0.0001 |
| 197 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
5 |
0.0001 |
| 198 |
HEPATOTOXICITY |
2 |
0.0001 |
| 199 |
MALNUTRITION |
1 |
0.0001 |
| 200 |
NEPHROPATHY TOXIC |
1 |
0.0001 |
| 201 |
HYPONATRAEMIA |
5 |
0.0001 |
| 202 |
COMA |
4 |
0.0001 |
| 203 |
CEREBRAL HAEMORRHAGE |
3 |
0.0001 |
| 204 |
MYELOSUPPRESSION |
3 |
0.0001 |
| 205 |
GENERALISED OEDEMA |
1 |
0.0001 |
| 206 |
TOOTH EXTRACTION |
1 |
0.0001 |
| 207 |
IMMUNE SYSTEM DISORDER |
1 |
0.0001 |
| 208 |
PLATELET COUNT DECREASED |
8 |
0.0001 |
| 209 |
ACUTE HEPATIC FAILURE |
1 |
0.0001 |
| 210 |
CENTRAL NERVOUS SYSTEM LESION |
1 |
0.0001 |
| 211 |
MENTAL STATUS CHANGES |
2 |
0.0001 |
| 212 |
OXYGEN SATURATION DECREASED |
4 |
0.0001 |
| 213 |
BLOOD TEST ABNORMAL |
1 |
0.0001 |
| 214 |
INTERNATIONAL NORMALISED RATIO INCREASED |
2 |
0.0001 |
| 215 |
ACCIDENTAL UNDERDOSE |
1 |
0.0001 |
| 216 |
RENAL INJURY |
2 |
0.0001 |
| 217 |
IMMUNODEFICIENCY |
1 |
0.0001 |
| 218 |
THERAPY NON-RESPONDER |
3 |
0.0001 |
| 219 |
HYPOAESTHESIA ORAL |
1 |
0.0001 |
| 220 |
TINNITUS |
3 |
0.0001 |
| 221 |
SEPSIS |
7 |
0.0001 |
| 222 |
ABSCESS |
1 |
0.0001 |
| 223 |
SENSORY DISTURBANCE |
1 |
0.0001 |
| 224 |
PRODUCT USE IN UNAPPROVED INDICATION |
15 |
0.0001 |
| 225 |
TREATMENT FAILURE |
5 |
0.0001 |
| 226 |
CYTOMEGALOVIRUS INFECTION |
1 |
0.0001 |
| 227 |
FUNGAL INFECTION |
2 |
0.0001 |
| 228 |
UPPER GASTROINTESTINAL HAEMORRHAGE |
1 |
0.0001 |
| 229 |
CANDIDA INFECTION |
1 |
0.0001 |
| 230 |
HEPATIC ENZYME INCREASED |
4 |
0.0001 |
| 231 |
EOSINOPHILIA |
1 |
0.0001 |
| 232 |
DRUG ERUPTION |
1 |
0.0001 |
| 233 |
C-REACTIVE PROTEIN INCREASED |
2 |
0.0001 |
| 234 |
RESPIRATORY FAILURE |
4 |
0.0001 |
| 235 |
CONJUNCTIVITIS |
1 |
0.0001 |
| 236 |
BACTERIAL INFECTION |
1 |
0.0001 |
| 237 |
HEPATIC CIRRHOSIS |
1 |
0.0001 |
| 238 |
CHOLESTASIS |
1 |
0.0001 |
| 239 |
SEROTONIN SYNDROME |
1 |
0.0001 |
| 240 |
PRODUCT PREPARATION ERROR |
1 |
0.0000 |
| 241 |
PERITONITIS |
1 |
0.0000 |
| 242 |
RHABDOMYOLYSIS |
2 |
0.0000 |
| 243 |
RENAL IMPAIRMENT |
4 |
0.0000 |
| 244 |
FAECES DISCOLOURED |
1 |
0.0000 |
| 245 |
MENTAL DISORDER |
2 |
0.0000 |
| 246 |
BLOOD CREATININE INCREASED |
3 |
0.0000 |
| 247 |
PRODUCT PRESCRIBING ISSUE |
1 |
0.0000 |
| 248 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
1 |
0.0000 |
| 249 |
NEUROPATHY PERIPHERAL |
4 |
0.0000 |
| 250 |
DISEASE RECURRENCE |
2 |
0.0000 |
| 251 |
MENTAL IMPAIRMENT |
1 |
0.0000 |
| 252 |
LUNG DISORDER |
2 |
0.0000 |
| 253 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
1 |
0.0000 |
| 254 |
EPISTAXIS |
3 |
0.0000 |
| 255 |
CELLULITIS |
2 |
0.0000 |
| 256 |
CONDITION AGGRAVATED |
12 |
0.0000 |
| 257 |
HEPATITIS |
1 |
0.0000 |
| 258 |
HAEMOGLOBIN DECREASED |
4 |
0.0000 |
| 259 |
DEAFNESS |
1 |
0.0000 |
| 260 |
RENAL FAILURE |
5 |
0.0000 |
| 261 |
LIMB INJURY |
1 |
0.0000 |
| 262 |
RED BLOOD CELL COUNT DECREASED |
1 |
0.0000 |
| 263 |
RESPIRATORY DISORDER |
1 |
0.0000 |
| 264 |
CONTRAINDICATED PRODUCT ADMINISTERED |
1 |
0.0000 |
| 265 |
CORONARY ARTERY DISEASE |
1 |
0.0000 |
| 266 |
DEEP VEIN THROMBOSIS |
2 |
0.0000 |
| 267 |
SKIN DISORDER |
1 |
0.0000 |
| 268 |
DELIRIUM |
1 |
0.0000 |
| 269 |
UNDERDOSE |
2 |
0.0000 |
| 270 |
ACCIDENTAL OVERDOSE |
1 |
0.0000 |
| 271 |
HEPATIC FUNCTION ABNORMAL |
1 |
0.0000 |
| 272 |
DYSPNOEA EXERTIONAL |
1 |
0.0000 |
| 273 |
ANAEMIA |
5 |
0.0000 |
| 274 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
1 |
0.0000 |
| 275 |
DISORIENTATION |
1 |
0.0000 |
| 276 |
DRUG INEFFECTIVE |
33 |
0.0000 |
| 277 |
CARDIAC FAILURE |
2 |
0.0000 |
| 278 |
NEUTROPHIL COUNT DECREASED |
1 |
0.0000 |
| 279 |
OVERDOSE |
5 |
0.0000 |
| 280 |
VAGINAL HAEMORRHAGE |
1 |
0.0000 |
| 281 |
NEPHROLITHIASIS |
1 |
0.0000 |
| 282 |
DIARRHOEA |
14 |
0.0000 |
| 283 |
HYPOKALAEMIA |
1 |
0.0000 |
| 284 |
ARRHYTHMIA |
1 |
0.0000 |
| 285 |
PRODUCTIVE COUGH |
1 |
0.0000 |
| 286 |
INFECTION |
3 |
0.0000 |
| 287 |
HYPOAESTHESIA |
3 |
0.0000 |
| 288 |
ILLNESS |
2 |
0.0000 |
| 289 |
INFLAMMATION |
1 |
0.0000 |
| 290 |
PARAESTHESIA |
3 |
0.0000 |
| 291 |
NAUSEA |
15 |
0.0000 |
| 292 |
ASPARTATE AMINOTRANSFERASE INCREASED |
1 |
0.0000 |
| 293 |
WHITE BLOOD CELL COUNT DECREASED |
2 |
0.0000 |
| 294 |
OEDEMA |
1 |
0.0000 |
| 295 |
ARTHROPATHY |
1 |
0.0000 |
| 296 |
PANCYTOPENIA |
1 |
0.0000 |
| 297 |
LETHARGY |
1 |
0.0000 |
| 298 |
PYREXIA |
6 |
0.0000 |
| 299 |
GENERAL PHYSICAL HEALTH DETERIORATION |
2 |
0.0000 |
| 300 |
IRRITABILITY |
1 |
0.0000 |
| 301 |
ALANINE AMINOTRANSFERASE INCREASED |
1 |
0.0000 |
| 302 |
INJECTION SITE ERYTHEMA |
2 |
0.0000 |
| 303 |
BLOOD PRESSURE DECREASED |
1 |
0.0000 |
| 304 |
VOMITING |
7 |
0.0000 |
| 305 |
NEUTROPENIA |
2 |
0.0000 |
| 306 |
HALLUCINATION |
1 |
0.0000 |
| 307 |
CHRONIC KIDNEY DISEASE |
1 |
0.0000 |
| 308 |
ACUTE KIDNEY INJURY |
2 |
0.0000 |
| 309 |
DRUG DOSE OMISSION BY DEVICE |
1 |
0.0000 |
| 310 |
PNEUMONIA |
4 |
0.0000 |
| 311 |
BALANCE DISORDER |
1 |
0.0000 |
| 312 |
GASTROINTESTINAL DISORDER |
1 |
0.0000 |
| 313 |
DEVICE ISSUE |
1 |
0.0000 |
| 314 |
ADVERSE DRUG REACTION |
1 |
0.0000 |
| 315 |
HYPERSENSITIVITY |
2 |
0.0000 |
| 316 |
ATRIAL FIBRILLATION |
1 |
0.0000 |
| 317 |
SOMNOLENCE |
2 |
0.0000 |
| 318 |
CHEST DISCOMFORT |
1 |
0.0000 |
| 319 |
ABDOMINAL PAIN UPPER |
2 |
0.0000 |
| 320 |
ABDOMINAL DISTENSION |
1 |
0.0000 |
| 321 |
RASH |
4 |
0.0000 |
| 322 |
MUSCULAR WEAKNESS |
1 |
0.0000 |
| 323 |
SEIZURE |
1 |
0.0000 |
| 324 |
DECREASED APPETITE |
2 |
0.0000 |
| 325 |
ABDOMINAL PAIN |
2 |
0.0000 |
| 326 |
CHILLS |
1 |
0.0000 |
| 327 |
OEDEMA PERIPHERAL |
1 |
0.0000 |
| 328 |
DEATH |
7 |
0.0000 |
| 329 |
VISUAL IMPAIRMENT |
1 |
0.0000 |
| 330 |
INSOMNIA |
2 |
0.0000 |
| 331 |
MEMORY IMPAIRMENT |
1 |
0.0000 |
| 332 |
BLOOD PRESSURE INCREASED |
1 |
0.0000 |
| 333 |
HOSPITALISATION |
1 |
0.0000 |
| 334 |
HEADACHE |
4 |
0.0000 |
| 335 |
DRUG INTERACTION |
1 |
0.0000 |
| 336 |
DIZZINESS |
3 |
0.0000 |
| 337 |
TOXICITY TO VARIOUS AGENTS |
1 |
0.0000 |
| 338 |
URINARY TRACT INFECTION |
1 |
0.0000 |
| 339 |
COVID-19 |
1 |
0.0000 |
| 340 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
1 |
0.0000 |
| 341 |
CHEST PAIN |
1 |
0.0000 |
| 342 |
PRODUCT USE ISSUE |
1 |
0.0000 |
| 343 |
ASTHENIA |
2 |
0.0000 |
| 344 |
DYSPNOEA |
3 |
0.0000 |
| 345 |
GAIT DISTURBANCE |
1 |
0.0000 |
| 346 |
HYPOTENSION |
1 |
0.0000 |
| 347 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
1 |
0.0000 |
| 348 |
HYPERTENSION |
1 |
0.0000 |
| 349 |
COUGH |
1 |
0.0000 |
| 350 |
PRODUCT DOSE OMISSION ISSUE |
1 |
0.0000 |
| 351 |
MALAISE |
1 |
0.0000 |
| 352 |
FATIGUE |
1 |
0.0000 |